FDA Cracks Down Hard — 30 Telehealth Companies Warned Over Compounded Ozempic & Zepbound Copies
The FDA sent warning letters to 30 telehealth companies for false claims about compounded GLP-1 drugs like semaglutide and tirzepatide.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
The FDA sent warning letters to 30 telehealth companies for false claims about compounded GLP-1 drugs like semaglutide and tirzepatide.
Paramount's shares dropped after ratings agencies downgraded its credit due to massive debt from the planned Warner Bros. Discovery merger.
Bitcoin mining profits have tanked with BTC down ~50% from its 2025 peak. Miners like Core Scientific are selling holdings and shifting to AI to stay alive in tough times.
The US is considering capping AI chip exports like Nvidia's H200 and AMD's MI325 to just 75,000 units per Chinese company. This news is pressuring stocks amid ongoing trade tensions and global market worries.
TransCode Therapeutics (RNAZ) announces an exclusive license for advanced cancer immunotherapy tech from Unleash, targeting hard-to-treat bladder cancer and more, in an all-stock deal to expand their pipeline.
Mobix Labs secures significant order for Tomahawk missile components as U.S. Navy ramps up production—stock surges on defense demand boost.